Aggregating Rs 15.75 crore
Vivimed Labs announced that the Foreign Investment promotion Board(FIPB), Department of Economic Affairs, Ministry of Finance, Government of India vide its letter dated 29 May 2015, Granted its Approval to Vivimed Labs for issuance of 500000 (Five Lakh only) warrants with an option to apply for and be allotted equivalent number of equity shares, of the Company to M/s KITARA PIIN 1102, Mauritius. The proposed issuance of warrants is to be made at an issue price of Rs. 315/- (i.e. at face value of Rs. 10/- each and premium of Rs. 305/- per warrant). The FDI inflow by the foreign investor is expected to be Rs. 15.75 crore approx.Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%